Effective Management of H. pylori Infection in Peptic Ulcer Disease: An Indian Perspective
Journal Title: The Indian Practitioner - Year 2014, Vol 67, Issue 6
Abstract
Background: Infection with Helicobacter Pylori (H.pylori) remains a major healthcare burden, with persistently high prevalence rates, especially in developing countries like India. H.pylori is the cause of most cases of Peptic Ulcer Disease and is a primary risk factor for gastric cancer. This infection if not treated effectively can lead to recurrence of Peptic Ulcer Disease. Numerous consensus groups around the world recommend a standard triple therapy as first-line therapy, including a proton pump inhibitor and a combination of Amoxicillin and Clarithromycin for eradication of H. pylori infections. The purpose of this study was to evaluate safety and efficacy of kit containing Pantoprazole + Clarithromycin + Amoxycillin in H. pylori infected patients with Peptic Ulcer Disease. Methods: A prospective, open-label, non-comparative multicentric study was conducted. A pool of 500 patients was involved in the study and the duration of study was 14 days. Kit containing tablets of Pantoprazole 40mg + Clarithromycin 500mg + Amoxycillin 750mg was administered for 14 consecutive days as one tablet each twice a day. Results: At the end of the study, a significant difference was observed in various parameters from baseline. A significant reduction in abdominal pain was observed at the end of the treatment (the mean score of abdominal pain at the base line was 2.21 which reduced to 0.17 on the 14th day). Significant decrease in the symptoms of heartburn was observed (the mean score of heart burn at the base line was 2.19 which reduced to 0.15 on the 14th day). Similarly significant decrease in symptoms of bloating & dysphagia was observed at the end of the therapy. As per investigator’s assessment about efficacy and tolerability, 96.2% of patients reported excellent efficacy and 92.4% of patients reported excellent tolerability. The therapy was well tolerated with few adverse events (AEs). Conclusion: The results of this study confirm that Kit containing tablets of Pantoprazole + Clarithromycin + Amoxycillin is well tolerated and it showed significant improvement in the symptoms of H. pylori infected patients with Peptic Ulcer Disease at the end of treatment.
Authors and Affiliations
Manish Maladkar, S Sankar
Keywords
Related Articles
- EP ID EP578739
- DOI -
- Views 74
- Downloads 0
Antimicrobial Resistance in Salmonella Experience of an Infectious Diseases Hospital in Mumbai, India
Background: Enteric fever (EF) remains an important public health problem, particularly in the developing countries. The last two decades have witnessed the emergence of multidrug- resistant (MDR) salmonella strains. O...
Evaluation of risk for Type 2 Diabetes Mellitus in 1st degree relatives using Indian Diabetes Risk Score (IDRS)
Diabetes Mellitus (DM) refers to a group of common metabolic disorders that share the phenotype of hyperglycaemia. The rising prevalence of type 2 DM is closely associated with industrialisation and socio economic develo...
Isolated Abducens Palsy- Sole Manifestation of Acephalgic Spontaneous Intracranial Hypotension
Orthostatic headache symptoms are usually seen in patients with spontaneous intracranial hypotension (SIH), usually after medical procedures like lumbar puncture. We report a case of a 55 year old lady who presented with...
Survey on Acid Peptic Disorders: Analyzing Prescribing Pattern of PPIs
Abstract: Acid peptic disorders (APDs) result from characteristic but overlapping pathogenic mechanisms that involve acid effects on diminished mucosal defense1. Proton pump inhibitors (PPIs) have become a mainstay in th...
A case of Thalassaemia Major with Mucopolysaccharidosis
We present a case of a male infant, with Thalassaemia Major who also had facial dysmorphism suggestive of Mucopolysaccharidosis, which was detected with a urinary screening test. This is probably the first time that two...